158750-41-5

Upstream product

• 792161-58-1 H-Asp(OcHex)-Ser(Bn)-Pro-OTce 
• 50903-88-3 Boc-Arg(Tos)-Gly-OH 
• 128857-85-2 Boc-Arg(Tos)-Gly-OBn 
• 158750-48-2 Boc-Ser(Bn)-Pro-OTce 
• 750558-42-0 H-Ser(Bn)-Pro-OTce 
• 158750-49-3 Boc-Asp(OcHex)-Ser(Bzl)-Pro-OTce 
• 126134-58-5 H-Pro-OTce 
• 13836-37-8 N^α-Boc-N^G-tosyl-L-arginine 
• 23680-31-1 BOC-O-benzyl-L-serine 

Downstream Products

• 174907-17-6 Boc-Arg(Tos)-Gly-Asp(OcHex)-Ser(Bn)-Pro-OH 
• 157148-71-5 Boc-Cys(Acm)-Arg(Tos)-Gly-Asp(OcHex)-Ser(Bzl)-Pro-OTce 
• 158750-44-8 Boc-Cys(Acm)-Gly-Gly-Arg(Tos)-Gly-Asp(OcHex)-Ser(Bzl)-Pro-OTce 
• 158750-57-3 Boc-Cys(Acm)-Gly-Gly-Arg(Tos)-Gly-Asp(OcHex)-Ser(Bzl)-Pro-OH 
• 149229-05-0 Boc-Cys(Acm)-Arg(Tos)-Gly-Asp(OcHex)-Ser(Bzl)-Pro-Ala 
• 790182-26-2 C₄₂H₅₇Cl₃N₈O₁₁S 

Relevant academic research and scientific papers

Synthesis of cyclic oligopeptides containing an Arg-Gly-Asp (RGD) sequence

The synthesis of cyclic RGD peptides with 8 - 10 residues cyclized by an amide bond and the relationship between their structure and activity (i.e. circular dichroism spectrum and inhibition of platelet aggregation) are reported. The linear peptides were

Synthesis and NMR studies of RGDSPASS-containing cystine peptides

Three types of Arg-Gly-Asp-Ser-Pro-Ala-Ser-Ser (RGDSPASS)-containing cystine peptides, FR-1, FR-2, and FR-3, were designed and synthesized. These cyclic peptides exhibited high activities as a platelet aggregation inhibitor. Using rabbit platelet-rich pla